| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Ali Asif is a Chief Financial Officer at PTGX. Recent filings cover 0 purchases and 18 sales. Those positions are worth an estimated $8.4M at current prices.
Our model assigns Ali Asif a below-average insider score of 37/100, based on 8 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -53.8%.
Ali Asif's largest disclosed position is in PTGX as Chief Financial Officer, worth about $8.4M. The recent filings there lean toward selling, a net 210,136 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | PTGX Protagonist Therapeutics, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 58,629 | $141.78 | $8,312,293.67 | -49.8% | - | - | |
| Apr 20, 2026 | PTGX Protagonist Therapeutics, Inc. | Chief Financial Officer | Sell | 1,750 | $105.47 | $184,572.50 | -2.9% | +27.3% | - | |
| Mar 26, 2026 | PTGX Protagonist Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 24,765 | $104.24 | $2,581,503.60 | -29.0% | +19.6% | - | |
| Jan 27, 2026 | PTGX Protagonist Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 46,203 | $83.13 | $3,841,037.42 | -43.4% | +18.6% | - | |
| Jan 20, 2026 | PTGX Protagonist Therapeutics, Inc. | Chief Financial Officer | Sell | 8,588 | $82.48 | $708,338.24 | -9.9% | +26.4% | - | |
| Apr 22, 2025 | PTGX Protagonist Therapeutics, Inc | Chief Financial Officer | Sell | 1,756 | $46.00 | $80,776.00 | -2.8% | +20.4% | - | |
| Mar 12, 2025 | PTGX Protagonist Therapeutics, Inc | Chief Financial Officer | Sale+OE | 24,903 | $58.73 | $1,462,553.19 | -28.4% | -2.2% | +65.5% | |
| Jan 16, 2025 | PTGX Protagonist Therapeutics, Inc | Chief Financial Officer | Sell | 3,918 | $0.00 | - | -5.9% | +25.3% | +124.4% | |
| Sep 11, 2024 | PTGX Protagonist Therapeutics, Inc | Chief Financial Officer | Sale+OE | 14,203 | $44.49 | $631,871.77 | -28.9% | -7.1% | +33.2% | |
| Apr 18, 2024 | PTGX Protagonist Therapeutics, Inc | Chief Financial Officer | Sell | 1,234 | $25.11 | $30,985.74 | -3.2% | +42.4% | +83.5% |